top of page

Virios Therapeutics Announces Initial FDA Feedback On Proposed IMC-1 Phase 3 Program For Treatment o

Writer's picture: RARA KOKO GOOD VIBES MAN RARA KOKO GOOD VIBES MAN

Virios Therapeutics Announces Initial FDA Feedback On Proposed IMC-1 Phase 3 Program For Treatment of Fibromyalgia; Says Final Toxicology Results To Be Submitted To FDA In

May 2023

58 views0 comments

Comments


bottom of page